123 related articles for article (PubMed ID: 3777326)
21. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
22. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Olofsson J
Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
[TBL] [Abstract][Full Text] [Related]
23. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear.
Wermker K; Kluwig J; Schipmann S; Klein M; Schulze HJ; Hallermann C
Eur J Surg Oncol; 2015 Jan; 41(1):128-35. PubMed ID: 25182221
[TBL] [Abstract][Full Text] [Related]
24. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
[TBL] [Abstract][Full Text] [Related]
25. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
26. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
[TBL] [Abstract][Full Text] [Related]
27. Patterns of lymph node metastasis of parotid cancer.
Shinomiya H; Otsuki N; Yamashita D; Nibu K
Auris Nasus Larynx; 2016 Aug; 43(4):446-50. PubMed ID: 26656731
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Tseros EA; Gebski V; Morgan GJ; Veness MJ
Ann Surg Oncol; 2016 May; 23(5):1693-8. PubMed ID: 26786095
[TBL] [Abstract][Full Text] [Related]
29. Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma.
Li G; Da M; Zhang W; Wu H; Ye J; Chen J; Ma L; Gu N; Wu Y; Song X
J Oral Pathol Med; 2016 Mar; 45(3):167-72. PubMed ID: 26189546
[TBL] [Abstract][Full Text] [Related]
30. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
31. Squamous carcinoma presenting as an enlarged cervical lymph node.
Jones AS; Cook JA; Phillips DE; Roland NR
Cancer; 1993 Sep; 72(5):1756-61. PubMed ID: 8348505
[TBL] [Abstract][Full Text] [Related]
32. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
33. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor.
Leemans CR; Tiwari R; Nauta JJ; van der Waal I; Snow GB
Cancer; 1994 Jan; 73(1):187-90. PubMed ID: 8275423
[TBL] [Abstract][Full Text] [Related]
34. Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma.
de Bree R; Takes RP; Castelijns JA; Medina JE; Stoeckli SJ; Mancuso AA; Hunt JL; Rodrigo JP; Triantafyllou A; Teymoortash A; Civantos FJ; Rinaldo A; Pitman KT; Hamoir M; Robbins KT; Silver CE; Hoekstra OS; Ferlito A
Head Neck; 2015 Dec; 37(12):1829-39. PubMed ID: 24954811
[TBL] [Abstract][Full Text] [Related]
35. Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma.
Kwon M; Roh JL; Lee J; Cho KJ; Choi SH; Nam SY; Kim SY
J Craniomaxillofac Surg; 2015 Jul; 43(6):769-78. PubMed ID: 26027870
[TBL] [Abstract][Full Text] [Related]
36. A critical evaluation of lymph node ratio in head and neck cancer.
de Ridder M; Marres CC; Smeele LE; van den Brekel MW; Hauptmann M; Balm AJ; van Velthuysen ML
Virchows Arch; 2016 Dec; 469(6):635-641. PubMed ID: 27639568
[TBL] [Abstract][Full Text] [Related]
37. Can Early Dissection of Cervical Lymph Nodes Improve Prognosis in Squamous Cell Carcinomas of the Hard Palate.
Deneuve S; Bodard AG; Delquignies E; Janot F; Zrounba P; Julieron M
ORL J Otorhinolaryngol Relat Spec; 2017; 79(6):314-322. PubMed ID: 29183025
[TBL] [Abstract][Full Text] [Related]
38. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers.
Forest VI; Clark JJ; Veness MJ; Milross C
Cancer; 2010 Mar; 116(5):1298-304. PubMed ID: 20052712
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases.
Ebrahimi A; Clark JR; Ahmadi N; Palme CE; Morgan GJ; Veness MJ
Head Neck; 2013 Aug; 35(8):1138-43. PubMed ID: 23152126
[TBL] [Abstract][Full Text] [Related]
40. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
